Dahne Jennifer, Lejuez C W, Kustanowitz Jacob, Felton Julia W, Diaz Vanessa A, Player Marty S, Carpenter Matthew J
1 Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
2 Department of Psychology and the College of Liberal Arts & Sciences, The University of Kansas, Lawrence, KS, USA.
Int J Psychiatry Med. 2017 Mar;52(2):160-175. doi: 10.1177/0091217417720899.
Depressive symptoms are highly prevalent and are associated with considerable functional impairment, significant public health costs, and heightened mortality risk. Individuals experiencing impairment due to depressive symptomatology are most likely to report their symptoms to a primary care provider. As such, national guidelines highlight the need to assess and effectively treat depression via primary care. Despite these guidelines, the dissemination of evidence-based psychotherapy via primary care is limited, likely due to both provider- and patient-level treatment barriers. Mobile health (mHealth) technologies are promising for addressing these barriers and for promoting uptake of evidence-based depression treatment. Among evidence-based psychotherapies for depression, brief Behavioral Activation Treatment for Depression (BATD) has shown great promise and is particularly amenable to mHealth delivery. Herein, we discuss the development of a BATD mobile application, Moodivate, that was developed in order to disseminate BATD via primary care. This paper focuses on description of (1) rationale for Moodivate treatment development, (2) Moodivate treatment components, (3) ongoing clinical trial evaluation of Moodivate, and (4) clinical considerations for incorporating Moodivate into clinical practice.
抑郁症状非常普遍，与相当严重的功能损害、巨大的公共卫生成本以及更高的死亡风险相关。因抑郁症状而出现功能损害的个体最有可能向初级保健提供者报告他们的症状。因此，国家指南强调了通过初级保健评估和有效治疗抑郁症的必要性。尽管有这些指南，但通过初级保健传播循证心理治疗的情况有限，这可能是由于提供者层面和患者层面的治疗障碍所致。移动健康（mHealth）技术有望消除这些障碍并促进循证抑郁症治疗的采用。在基于证据的抑郁症心理治疗中，简短行为激活治疗抑郁症（BATD）已显示出巨大潜力，并且特别适合通过移动健康方式提供。在此，我们讨论为通过初级保健传播BATD而开发的BATD移动应用程序Moodivate的开发情况。本文重点描述（1）Moodivate治疗开发的原理，（2）Moodivate治疗组件，（3）正在进行的Moodivate临床试验评估，以及（4）将Moodivate纳入临床实践的临床考量。
